Stay updated on Filgotinib Testicular Safety Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Testicular Safety Clinical Trial page.

Latest updates to the Filgotinib Testicular Safety Clinical Trial page
- Check5 days agoChange DetectedA new latest revision entry (v3.6.3) is added to the history, and the older entry (v3.6.0) is removed, updating the record's version list to reflect the deployment.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now shows that the trial is no longer seeking participants, indicating enrollment has closed. The record also adds a new revision tag v3.6.0 and removes the previous v3.5.5 tag.SummaryDifference0.3%

- Check27 days agoChange DetectedA new revision entry 'Revision: v3.5.5' was added to the history, replacing the previous 'Revision: v3.5.4'.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study record's sponsor name changed from Galapagos NV to Lakefront Biotherapeutics NV. This update reflects a sponsorship transition in the record.SummaryDifference0.1%

- Check48 days agoChange DetectedNew site revision tag v3.5.4 was added to the page history, while the previous v3.5.3 tag is removed.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s footer revision/version display was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical trial record content.SummaryDifference0.1%

Stay in the know with updates to Filgotinib Testicular Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Testicular Safety Clinical Trial page.